HIGHLIGHTS
- who: Lukas M. Braun and collaborators from the Center for Biological Systems Analysis ZBSA, Albert-Ludwigs-University Freiburg, Freiburg, Germany have published the research: Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines, in the Journal: (JOURNAL)
- what: Pancreatic ductal adenocarcinoma (PDAC) correlates with high mortality and is about to become one of the major reasons for cancer-related mortality in the next decades. The authors report the impact of on the cellular metabolome of cell lines.
- how: Normally distributed data were compared using an unpaired t-test.
SUMMARY . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.